
Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Sponsored
Sponsored
Sponsored
2026-07-31RVPHWSCHEDULE 13G/AUBS Group AG Exits Position in Reviva Pharmaceuticals Holdings, Inc. (RVPHW)HIGH
UBS Group AG has filed a Schedule 13G/A (Amendment No. 1) with the SEC, reporting that it has completely exited its position in Reviva Pharmaceuticals Holdings, Inc. (RVPHW). As of the event date on June 30, 2026, the filer reported owning 0 shares of common stock, representing 0.0% of the company. This marks a signifi...
Biotechnologyownership-5.80%